Altamira Therapeutics Ltd. Derivatives Percentage Contributed To Fair Value Of Plan Assets
Altamira Therapeutics Ltd. (CYTOF) had Derivatives Percentage Contributed To Fair Value Of Plan Assets of 1.35% as of 2021-03-04, per its 20-F filed 2022-04-12.
Discontinued › Notes › Derivative Instruments and Hedging Activities
ifrs-full:DerivativesPercentageContributedToFairValueOfPlanAssets · last filed 2022-04-12
- 2021-03-04: Derivatives Percentage Contributed To Fair Value Of Plan Assets 1.35%.
- 2020-12-01: Derivatives Percentage Contributed To Fair Value Of Plan Assets 1.35%.
| Period end | Derivatives Percentage Contributed To Fair Value Of Plan Assets |
|---|---|
| 2021-03-04 | 1.35% 20-F · filed 2022-04-12 |
| 2020-12-01 | 1.35% 20-F · filed 2022-04-12 |